Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | AOX1 | Q06278 | 1/20 | 0.37 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.36 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.36 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | NQO1 | P15559 | 1/20 | 0.34 |
| ▸ | GLA | P06280 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.31 |
| ▸ | SHBG | P04278 | 1/20 | 0.31 |
| ▸ | ERN1 | O75460 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16231356 | 0.83 | CA1 (0.38) | ALDH1A1MEN1KMT2AKDM4EHPGD | |
| SCHEMBL3100001 | 0.73 | — | — | |
| SCHEMBL183359 | 0.71 | ALOX5 (0.35) | ALDH1A1MEN1KMT2AKDM4EALOX5 | |
| SCHEMBL5591713 | 0.71 | — | — | |
| SCHEMBL28227078 | 0.71 | TDP1 (0.37) | ALDH1A1MEN1KMT2AKDM4ELMNA | |
| SCHEMBL6626531 | 0.70 | — | — | |
| SCHEMBL4372628 | 0.70 | KDM4E (0.39) | ALDH1A1MEN1KMT2AKDM4ELMNA | |
| SCHEMBL9483022 | 0.69 | ALDH1A1 (0.42) | ALDH1A1MEN1KMT2AKDM4ELMNA | |
| SCHEMBL28088888 | 0.69 | ALDH1A1 (0.36) | ALDH1A1MEN1KMT2AKDM4ELMNA | |
| SCHEMBL28557816 | 0.69 | ERN1 (0.38) | ALDH1A1MEN1KMT2AKDM4ETSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011096812-A1 | METHOD AND APPARATUS FOR MODIFYING WOOD, AND WOOD PRODUCT | VIA INGENIO B.V. (NL) | 2011-08-11 | — | — | WO | claimed |
| EP-2035198-A1 | METHOD FOR MODIFYING WOOD AND WOOD THEREBY OBTAINED | Transfurans Chemicals (BE) | 2009-03-18 | — | — | EP | claimed |
| WO-2007147804-A1 | METHOD FOR MODIFYING WOOD AND WOOD THEREBY OBTAINED | TRANSFURANS CHEMICALS (BE) | 2007-12-27 | — | — | WO | claimed |
| US-20150374667-A1 | Compositions And Method For Treatment Of Ischemic Neuronal Reperfusion Injury | HOWARD UNIVERSITY | 2015-12-31 | — | — | US | disclosed |
| EP-2621979-B1 | BIOCOMPOSITE PANEL | ROEMMLER H RESOPAL WERK GMBH (DE) | 2015-05-06 | — | — | EP | disclosed |
| US-20130295399-A1 | BIOCOMPOSITE PANEL | RESOPAL GMBH (DE) | 2013-11-07 | — | — | US | disclosed |
| EP-2621979-A1 | BIOCOMPOSITE PANEL | RESOPAL GMBH (DE) | 2013-08-07 | — | — | EP | disclosed |
| US-8158206-B2 | Method for modifying wood and wood thereby obtained | TRANSFURANS CHEMICALS (BE) | 2012-04-17 | — | — | US | disclosed |
| WO-2012041521-A1 | BIOCOMPOSITE PANEL | RESOPAL GMBH (DE) | 2012-04-05 | — | — | WO | disclosed |
| EP-2035198-B1 | METHOD FOR MODIFYING WOOD AND WOOD THEREBY OBTAINED | TRANSFURANS CHEMICALS (BE) | 2012-01-04 | — | — | EP | disclosed |
| WO-2011096812-A1 | METHOD AND APPARATUS FOR MODIFYING WOOD, AND WOOD PRODUCT | VIA INGENIO B.V. (NL) | 2011-08-11 | — | — | WO | disclosed |
| US-20100062276-A1 | METHOD FOR MODIFYING WOOD AND WOOD THEREBY OBTAINED | TRANSFURANS CHEMICALS (BE) | 2010-03-11 | — | — | US | disclosed |
| EP-2035198-A1 | METHOD FOR MODIFYING WOOD AND WOOD THEREBY OBTAINED | Transfurans Chemicals (BE) | 2009-03-18 | — | — | EP | disclosed |
| WO-2007147804-A1 | METHOD FOR MODIFYING WOOD AND WOOD THEREBY OBTAINED | TRANSFURANS CHEMICALS (BE) | 2007-12-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150374667-A1 | Compositions And Method For Treatment Of Ischemic Neuronal Reperfusion Injury | BDNF, GAP43, BAX | ALDH1A1 3292/4885MEN1 3653/4885KMT2A 4472/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.